Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

NCT04609085 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT04609085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04609085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-COV2 Pandemic Serosurvey in a Rare Disease Population
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
April 19, 2021
Completion date
June 8, 2022
Enrollment
730 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 virus